109 related articles for article (PubMed ID: 19793076)
1. Antimicrobial prophylaxis in liver transplant patients--a multicenter survey endorsed by the European Liver and Intestine Transplant Association.
Vandecasteele E; De Waele J; Vandijck D; Blot S; Vogelaers D; Rogiers X; Van Vlierberghe H; Decruyenaere J; Hoste E
Transpl Int; 2010 Feb; 23(2):182-90. PubMed ID: 19793076
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
[TBL] [Abstract][Full Text] [Related]
3. Variation in antifungal prophylaxis strategies in lung transplantation.
Husain S; Zaldonis D; Kusne S; Kwak EJ; Paterson DL; McCurry KR
Transpl Infect Dis; 2006 Dec; 8(4):213-8. PubMed ID: 17116134
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
[TBL] [Abstract][Full Text] [Related]
5. Antifungal prophylaxis in liver transplant recipients.
Eschenauer GA; Lam SW; Carver PL
Liver Transpl; 2009 Aug; 15(8):842-58. PubMed ID: 19642130
[TBL] [Abstract][Full Text] [Related]
6. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations.
Campos-Varela I; Blumberg EA; Giorgio P; Kotton CN; Saliba F; Wey EQ; Spiro M; Raptis DA; Villamil F;
Clin Transplant; 2022 Oct; 36(10):e14631. PubMed ID: 35257411
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis in pediatric lung transplantation: an international multicenter survey.
Mead L; Danziger-Isakov LA; Michaels MG; Goldfarb S; Glanville AR; Benden C;
Pediatr Transplant; 2014 Jun; 18(4):393-7. PubMed ID: 24802346
[TBL] [Abstract][Full Text] [Related]
8. Infection prophylaxis in pancreas transplant recipients.
Stratta RJ; Taylor RJ; Sindhi R; Sudan D; Castaldo P
Transplant Proc; 1995 Dec; 27(6):3018-9. PubMed ID: 8539820
[No Abstract] [Full Text] [Related]
9. Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice.
Trifilio S; Verma A; Mehta J
Bone Marrow Transplant; 2004 Apr; 33(7):735-9. PubMed ID: 14755318
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial prophylaxis regimens following transplantation.
Subramanian AK
Curr Opin Infect Dis; 2011 Aug; 24(4):344-9. PubMed ID: 21673573
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial prophylaxis and infection surveillance in extracorporeal membrane oxygenation patients: a multi-institutional survey of practice patterns.
Kao LS; Fleming GM; Escamilla RJ; Lew DF; Lally KP
ASAIO J; 2011; 57(3):231-8. PubMed ID: 21317768
[TBL] [Abstract][Full Text] [Related]
12. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study.
Husain S; Tollemar J; Dominguez EA; Baumgarten K; Humar A; Paterson DL; Wagener MM; Kusne S; Singh N
Transplantation; 2003 Jun; 75(12):2023-9. PubMed ID: 12829905
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue.
Potena L; Grigioni F; Magnani G; Branzi A
Transplantation; 2009 Jan; 87(2):305-6; author reply 306-7. PubMed ID: 19155991
[No Abstract] [Full Text] [Related]
14. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
[TBL] [Abstract][Full Text] [Related]
16. [Prophylaxis of cytomegalovirus infection in liver transplantation].
Cisneros JM; Varo E
Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():42-5. PubMed ID: 22541922
[TBL] [Abstract][Full Text] [Related]
17. [Open clinical trial with oral acyclovir for the prophylaxis of disease by Cytomegalovirus in low risk liver transplant recipients].
Moreno J; Montero JL; Gavilán F; Costán G; Herrero C; Cárdenas M; Sánchez-Guijo P; Torre-Cisneros J
Enferm Infecc Microbiol Clin; 1999 Oct; 17(8):382-5. PubMed ID: 10563084
[TBL] [Abstract][Full Text] [Related]
18. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
Bone Marrow Transplant; 1993 Oct; 12(4):399-403. PubMed ID: 8275040
[TBL] [Abstract][Full Text] [Related]
19. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients.
Das A
Hepatology; 2000 Feb; 31(2):311-7. PubMed ID: 10655251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
